参考文献/References:
[1] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC) Developed with the special contribution of the European Heart Rhythm Association(EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498.
[2] Yuan L,Zhang X,Guo N,et al. Prevalence of cognitive impairment in Chinese older inpatients and its relationship with 1-year adverse health outcomes:a multi-center cohort study[J]. BMC Geriatr,2021,21(1):595.
[3] Chen LY,Norby FL,Gottesman RF,et al. Association of atrial fibrillation with cognitive decline and dementia over 20?years:the ARIC-NCS(Atherosclerosis Risk in Communities Neurocognitive Study)[J]. J Am Heart Assoc,2018,7(6):e007301.
[4] Zuin M,Roncon L,Passaro A,et al. Risk of dementia in patients with atrial fibrillation:short versus long follow-up. A systematic review and meta-analysis[J]. Int J Geriatr Psychiatry,2021,36(10):1488-1500.
[5] Wang X,Wang Z,Yan X,et al. Radiofrequency and cryoballoon ablation improve cognitive function in patients with atrial fibrillation[J]. Medicine(Baltimore),2021,100(32):e26914.
[6] Mohanty S,Mohanty P,Trivedi C,et al. Impact of oral anticoagulation therapy versus left atrial appendage occlusion on cognitive function and quality of life in patients with atrial fibrillation[J]. J Am Heart Assoc,2021,10(9):e019664.
[7] Mailhot T,Mcmanus DD,Waring ME,et al. Frailty,cognitive impairment,and anticoagulation among older adults with nonvalvular atrial fibrillation[J]. J Am Geriatr Soc,2020,68(12):2778-2786.
[8] Ding M,Fratiglioni L,Johnell K,et al. Atrial fibrillation,antithrombotic treatment,and cognitive aging:a population-based study[J]. Neurology,2018,91(19):e1732-e1740.
[9] Qu Y,Zhuo L,Li N,et al. Prevalence of post-stroke cognitive impairment in china:a community-based,cross-sectional study[J]. PLoS One,2015,10(4):e0122864.
[10] Moazzami K,Shao IY,Chen LY,et al. Atrial fibrillation,brain volumes,and subclinical cerebrovascular disease(from the Atherosclerosis Risk in Communities Neurocognitive Study[ARIC-NCS])[J]. Am J Cardiol,2020,125(2):222-228.
[11] Grossmann K. Direct oral anticoagulants:a new therapy against Alzheimer’s disease?[J]. Neural Regen Res,2021,16(8):1556-1557.
[12] Bian Z,Liu X,Feng T,et al. Protective effect of rivaroxaban against amyloid pathology and neuroinflammation through inhibiting PAR-1 and PAR-2 in Alzheimer’s disease mice[J]. J Alzheimers Dis,2022,86(1):111-123.
[13] Cortes-Canteli M,Kruyer A,Fernandez-Nueda I,et al. Long-term dabigatran treatment delays Alzheimer’s disease pathogenesis in the TgCRND8?mouse model[J]. J Am Coll Cardiol,2019,74(15):1910-1923.
[14] Conen D,Rodondi N,Müller A,et al. Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation[J]. J Am Coll Cardiol,2019,73(9):989-999.
[15] Zhong HH,Qu JF,Xiao WM,et al. Severity of lesions involving the cortical cholinergic pathways may be associated with cognitive impairment in subacute ischemic stroke[J]. Front Neurol,2021,12:606897.
[16] Guidoux C,Meseguer E,Ong E,et al. Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy:the WATCH-AF registry[J]. Open Heart,2019,6(2):e001187.
[17] Li L,Wu DH,Li HQ,et al. Association of cerebral microbleeds with cognitive decline:a longitudinal study[J]. J Alzheimers Dis,2020,75(2):571-579.
[18] Li X,Yuan J,Qin W,et al. Cerebral microbleeds are associated with impairments in executive function and processing speed[J]. J Alzheimers Dis,2021,81(1):255-262.
[19] Ahn SJ,Anrather J,Nishimura N,et al. Diverse inflammatory response after cerebral microbleeds includes coordinated microglial migration and proliferation[J]. Stroke,2018,49(7):1719-1726.
[20] Cheng Y,Wang Y,Song Q,et al. Use of anticoagulant therapy and cerebral microbleeds:a systematic review and meta-analysis[J]. J Neurol,2021,268(5):1666-1679.
[21] Mongkhon P,Fanning L,Lau WCY,et al. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation:a population-based cohort study[J]. Heart Rhythm,2020,17(5 Pt A):706-713.
[22] Madhavan M,Hu TY,Gersh BJ,et al. Efficacy of warfarin anticoagulation and incident dementia in a community-based cohort of atrial fibrillation[J]. Mayo Clin Proc,2018,93(2):145-154.
[23] Petroni R,Magnano R,Pezzi L,et al. Analysis of risk factors independently associated with cognitive impairment in patients with permanent atrial fibrillation:a cross-sectional observational study[J]. J Stroke Cerebrovasc Dis,2020,29(8):104895.
[24] Jankowska-Polańska B,Katarzyna L,Lidia A,et al. Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation[J]. J Geriatr Cardiol,2016,13(7):559-565.
[25] Cadogan SL,Powell E,Wing K,et al. Anticoagulant prescribing for atrial fibrillation and risk of incident dementia[J]. Heart,2021,107(23):1898-1904.
[26] Chen N,Lutsey PL,Maclehose RF,et al. Association of oral anticoagulant type with risk of dementia among patients with nonvalvular atrial fibrillation[J]. J Am Heart Assoc,2018,7(21):e009561.
[27] Kim D,Yang PS,Jang E,et al. Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation[J]. Europace,2021,23(2):184-195.
[28] S?gaard M,Skj?th F,Jensen M,et al. Nonvitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients and risk of dementia:a nationwide propensity-weighted cohort study[J]. J Am Heart Assoc,2019,8(11):e011358.
[29] Bauersachs R,Zannad F. Rivaroxaban:a new treatment paradigm in the setting of vascular protection?[J]. Thromb Haemost,2018,118(S 01):S12-S22.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(5):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]